Clinically Relevant Activity of the Novel RASP Inhibitor Reproxalap in Allergic Conjunctivitis: The Phase 3 ALLEVIATE Trial.
Sign Up to like & getrecommendations! Published in 2021 at "American journal of ophthalmology"
DOI: 10.1016/j.ajo.2021.04.023
Abstract: PURPOSE To assess the post-acute activity and clinical utility of reproxalap, a novel reactive aldehyde species (RASP) inhibitor, versus vehicle in patients with seasonal allergic conjunctivitis. DESIGN Parallel-group, double-masked, randomized Phase 3 trial. METHODS Two… read more here.
Keywords: phase; conjunctivitis; ocular itching; allergic conjunctivitis ... See more keywords
Effects of Punctal Occlusion on Ocular Itching and Conjunctival Redness Associated with Allergic Conjunctivitis.
Sign Up to like & getrecommendations! Published in 2023 at "Current eye research"
DOI: 10.1080/02713683.2023.2211247
Abstract: PURPOSE Punctal occlusion using punctal plugs has been successfully used to treat the signs and symptoms of dry eye disease. However, the effects of punctal occlusion on the symptoms of allergic conjunctivitis (AC) have been… read more here.
Keywords: punctal occlusion; occlusion; itching conjunctival; conjunctival redness ... See more keywords